GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businessesMarket Watch • 02/01/23
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine MarketInvestors Business Daily • 01/19/23
Moderna Comes Swinging For Pfizer, GSK As RSV Vaccine Battle Heats UpInvestors Business Daily • 01/17/23
GSK growing optimistic on HIV but long term challenges remain - analystProactive Investors • 01/11/23
GSK plc (GSK) Presents at 41st Annual JPMorgan Healthcare Conference (Transcript)Seeking Alpha • 01/10/23
GSK, AstraZeneca: Will the two UK drugs giants ride the US$74bn pharma wave or will they be left beached?Proactive Investors • 01/06/23
WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell EngagersPRNewsWire • 01/05/23
New data at ASH underscore the potential for durable, clinically important responses with momelotinib for myelofibrosis patientsBusiness Wire • 12/11/22